Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uniflu Phase 1 in Healthy Volunteers
NCT03789539Phase 1Unknown
- Sponsor
- VA Pharma
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Uniflu in influenza (3 arms), sponsored by VA Pharma. Primary endpoint: Number of participants with adverse events at 42 days. Status: unknown.
02
Drugs
Uniflu
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03789539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789539.